Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-27 4:00 pm Purchase | 2026-05-19 | 13G | Amanat Acquisition Corp AMAN | Great Point Partners, LLC | 500,000 5.170% | 500,000 (New Position) | Filing History |
| 2026-05-15 08:55 am Purchase | 2026-03-31 | 13G | PROMIS NEUROSCIENCES INC N PMN | Great Point Partners, LLC | 954,082 9.990% | 544,434 (+132.90%) | Filing History |
| 2026-05-15 08:55 am Sale | 2026-03-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Great Point Partners, LLC | 2,238,496 2.440% | -2,445,215 (-52.21%) | Filing History |
| 2026-05-15 08:54 am Purchase | 2026-03-31 | 13G | ZURA BIO LTD ZURA | Great Point Partners, LLC | 4,215,930 4.440% | 400,000 (+10.48%) | Filing History |
| 2026-04-24 4:21 pm Purchase | 2026-04-17 | 13G | JATT II ACQUISITION CORP USD O JATT | Great Point Partners, LLC | 500,000 6.410% | 500,000 (New Position) | Filing History |
| 2026-04-07 4:00 pm Purchase | 2026-03-31 | 13G | SCYNEXIS INC SCYX | Great Point Partners, LLC | 997,339 9.990% | 997,339 (New Position) | Filing History |
| 2026-03-31 6:03 pm Purchase | 2026-03-24 | 13G | SOL-GEL TECHNOLOGIES LTD SHS N SLGL | Great Point Partners, LLC | 274,363 8.450% | 274,363 (New Position) | Filing History |
| 2026-02-17 4:24 pm Purchase | 2025-12-31 | 13G | PROMIS NEUROSCIENCES INC N PMN | Great Point Partners, LLC | 409,648 9.990% | 170,753 (+71.48%) | Filing History |
| 2026-02-17 4:17 pm Unchanged | 2025-12-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Great Point Partners, LLC | 4,683,711 5.100% | 0 (Unchanged) | Filing History |
| 2026-02-17 4:17 pm Sale | 2025-12-31 | 13G | INVENTIVA SA ADR IVA | Great Point Partners, LLC | 6,783,269 3.490% | -1,852,882 (-21.45%) | Filing History |
| 2026-02-17 4:16 pm Unchanged | 2025-12-31 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Great Point Partners, LLC | 2,055,834 4.950% | 0 (Unchanged) | Filing History |
| 2026-02-17 4:15 pm Unchanged | 2025-12-31 | 13G | ZURA BIO LTD ZURA | Great Point Partners, LLC | 3,815,930 5.180% | 0 (Unchanged) | Filing History |
| 2026-02-17 4:13 pm Purchase | 2025-12-31 | 13G | VOR BIOPHARMA INC VOR | Great Point Partners, LLC | 1,370,107 3.300% | 135,621 (+10.99%) | Filing History |
| 2025-12-17 4:00 pm Purchase | 2025-12-10 | 13G | VOR BIOPHARMA INC VOR | Great Point Partners, LLC | 1,234,486 5.630% | 1,234,486 (New Position) | Filing History |
| 2025-11-14 3:40 pm Purchase | 2025-09-30 | 13G | ZURA BIO LTD ZURA | Great Point Partners, LLC | 3,815,930 5.870% | 645,736 (+20.37%) | Filing History |
| 2025-11-14 3:18 pm Unchanged | 2025-09-30 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Great Point Partners, LLC | 2,055,834 6.280% | 0 (Unchanged) | Filing History |
| 2025-11-14 3:02 pm Unchanged | 2025-09-30 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Great Point Partners, LLC | 796,558 4.510% | 0 (Unchanged) | Filing History |
| 2025-11-14 2:12 pm Purchase | 2025-09-30 | 13G | PROMIS NEUROSCIENCES INC PMN | Great Point Partners, LLC | 238,895 9.990% | 105,514 (+79.11%) | Filing History |
| 2025-11-14 1:59 pm Sale | 2025-09-30 | 13G | INVENTIVA SA ADR IVA | Great Point Partners, LLC | 8,636,151 6.060% | -1,940,676 (-18.35%) | Filing History |
| 2025-11-14 1:16 pm Unchanged | 2025-09-30 | 13G | CONTEXT THERAPEUTICS INC CNTX | Great Point Partners, LLC | 4,683,711 5.220% | 0 (Unchanged) | Filing History |